Novo Nordisk A S (NVO) Revenue (2012 - 2016)
Novo Nordisk A S's (NVO) quarterly Revenue came in at $4.2 billion in Q2 2016, up 4.02% YoY from $4.0 billion in Q3 2015, and up 3.68% on a QoQ basis from $4.0 billion in Q1 2016.
Novo Nordisk A S (NVO) Revenue (2012 - 2016) Analysis & Trends
Novo Nordisk A S (NVO) has 5 years of Revenue data on file, last reported at $4.2 billion in Q2 2016.
- Quarterly Revenue rose 4.02% year-over-year to $4.2 billion in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $16.4 billion (up 3.15% YoY) and the FY2019 annual result came in at $122.0 billion, up 9.11% from the prior year.
- Revenue advanced to $4.2 billion in Q2 2016, from $4.0 billion in the prior quarter.
- In the past five years, Revenue ranged from a high of $4.2 billion in Q4 2015 to a low of $3.1 billion in Q1 2012.
- A 5-year average of $3.8 billion and a median of $3.9 billion in 2013 frame the typical range for Revenue.
- Annual changes were most pronounced in 2013 — Revenue gained 13.04% — and 2015, when it rose 0.73%.
- Tracing NVO's Revenue over 5 years: stood at $3.6 billion in 2012, then advanced by 8.49% to $4.0 billion in 2013, then rose by 4.89% to $4.1 billion in 2014, then increased by 2.34% to $4.2 billion in 2015, then decreased by 1.77% to $4.2 billion in 2016.
- The last three Revenue figures came in at $4.2 billion (Q2 2016), $4.0 billion (Q1 2016), and $4.2 billion (Q4 2015), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 4.17 Bn |
| Mar 31, 2016 | 4.02 Bn |
| Dec 31, 2015 | 4.24 Bn |
| Sep 30, 2015 | 3.99 Bn |
| Jun 30, 2015 | 4.00 Bn |
| Mar 31, 2015 | 3.81 Bn |
| Dec 31, 2014 | 4.14 Bn |
| Sep 30, 2014 | 3.96 Bn |
| Jun 30, 2014 | 3.98 Bn |
| Mar 31, 2014 | 3.73 Bn |
| Dec 31, 2013 | 3.95 Bn |
| Sep 30, 2013 | 3.64 Bn |
| Jun 30, 2013 | 3.75 Bn |
| Mar 31, 2013 | 3.54 Bn |
| Dec 31, 2012 | 3.64 Bn |
| Sep 30, 2012 | 3.34 Bn |
| Jun 30, 2012 | 3.36 Bn |
| Mar 31, 2012 | 3.13 Bn |